Docebo Overview
Docebo Target Price
Analysts' 12-month price predictions for DCBO.
Share Price
$27
Average Target Price
$43.00
59.3% upside
59.3% upside3 analysts in the last 4 months
High: $45 | Low: $41
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-04-16 | Morgan StanleyJosh Baer | $41 | 51.9% upside |  |
| 2025-03-04 | UBS | $45 | 66.7% upside | |
| 2025-02-28 | Morgan Stanley | $43 | 59.3% upside | |
| 2024-10-24 | ScotiabankKevin Krishnaratne | $55 | 103.7% upside | |
| 2024-09-16 | Goldman SachsKevin Kumar | $48 | 77.8% upside | |
| 2024-09-12 | NeedhamRyan MacDonald | $50 | 85.2% upside | |
| 2024-08-09 | Canaccord GenuityRobert Young | $54 | 100% upside | |
| 2024-06-07 | Craig-HallumGeorge Sutton | $58 | 114.8% upside | |
| 2024-05-14 | Canaccord GenuityRobert Young | $55 | 103.7% upside | |
| 2024-05-14 | ScotiabankKevin Krishnaratne | $50 | 85.2% upside | |
| 2023-11-14 | NeedhamRyan MacDonald | $56 | 107.4% upside | |
| 2023-08-18 | Morgan StanleyJosh Baer | $49 | 81.5% upside | |
| 2022-11-11 | Morgan Stanley | $36 | 33.3% upside | |
| 2022-04-26 | Morgan Stanley | $54 | 100% upside | |
| 2021-08-13 | Cantor FitzgeraldBrett Knoblauch | $82 | 203.7% upside | |